|
G |
ACE |
angiotensin I converting enzyme |
affects activity |
ISO |
Puromycin Aminonucleoside affects the activity of ACE protein |
CTD |
PMID:1318808 |
|
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ACMSD |
aminocarboxymuconate semialdehyde decarboxylase |
decreases activity |
ISO |
Puromycin Aminonucleoside results in decreased activity of ACMSD protein |
CTD |
PMID:16711654 |
|
NCBI chr 2:134,838,616...134,902,034
Ensembl chr 2:134,838,616...134,902,034
|
|
G |
ACTB |
actin beta |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ACTB protein |
CTD |
PMID:19264907 |
|
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
|
|
G |
ACTG1 |
actin gamma 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ACTG1 protein |
CTD |
PMID:19264907 |
|
NCBI chr17:81,509,971...81,512,799
Ensembl chr17:81,509,413...81,523,847
|
|
G |
ACTR2 |
actin related protein 2 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ACTR2 mRNA; Puromycin Aminonucleoside results in increased expression of ACTR2 protein |
CTD |
PMID:19617259 |
|
NCBI chr 2:65,227,831...65,271,253
Ensembl chr 2:65,227,788...65,271,253
|
|
G |
ACTR3 |
actin related protein 3 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ACTR3 protein |
CTD |
PMID:19264907 |
|
NCBI chr 2:113,889,934...113,962,596
Ensembl chr 2:113,890,063...113,962,596
|
|
G |
AGT |
angiotensinogen |
affects expression decreases expression increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside affects the expression of AGT protein Puromycin Aminonucleoside results in decreased expression of AGT protein Puromycin Aminonucleoside results in increased expression of AGT mRNA [Puromycin Aminonucleoside co-treated with Cholesterol] results in increased expression of AGT mRNA |
CTD |
PMID:2236972 PMID:8446257 PMID:12495295 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGTR2 |
angiotensin II receptor type 2 |
multiple interactions increases expression |
ISO |
[Puromycin Aminonucleoside co-treated with Cholesterol] results in increased expression of AGTR2 mRNA Puromycin Aminonucleoside results in increased expression of AGTR2 mRNA |
CTD |
PMID:12495295 |
|
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
|
|
G |
AGXT2 |
alanine--glyoxylate aminotransferase 2 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of AGXT2 protein |
CTD |
PMID:19264907 |
|
NCBI chr 5:34,998,102...35,047,949
Ensembl chr 5:34,998,101...35,048,135
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
multiple interactions affects localization |
ISO |
Dexamethasone inhibits the reaction [Puromycin Aminonucleoside affects the localization of AIFM1 protein] |
CTD |
PMID:15987750 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
ALB |
albumin |
affects transport increases secretion increases expression affects localization decreases expression |
ISO |
Puromycin Aminonucleoside affects the transport of ALB protein Puromycin Aminonucleoside results in increased secretion of ALB protein Puromycin Aminonucleoside results in increased expression of ALB mRNA; Puromycin Aminonucleoside results in increased expression of ALB protein Puromycin Aminonucleoside affects the localization of ALB protein Puromycin Aminonucleoside results in decreased expression of ALB protein |
CTD |
PMID:1453496 PMID:3301049 PMID:8413769 PMID:15798086 PMID:19264907 PMID:20438795 PMID:20540862 More...
|
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALDH1A2 |
aldehyde dehydrogenase 1 family member A2 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ALDH1A2 mRNA |
CTD |
PMID:12660332 |
|
NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866
|
|
G |
ANGPT1 |
angiopoietin 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ANGPT1 mRNA |
CTD |
PMID:17667850 |
|
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
multiple interactions increases expression |
ISO |
1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of APEX1 protein] |
CTD |
PMID:17035936 |
|
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
|
|
G |
APOA1 |
apolipoprotein A1 |
decreases response to substance increases expression |
EXP ISO |
APOA1 protein results in decreased susceptibility to Puromycin Aminonucleoside Puromycin Aminonucleoside results in increased expression of APOA1 mRNA; Puromycin Aminonucleoside results in increased expression of APOA1 protein |
CTD |
PMID:7066357 PMID:7442475 PMID:7595070 PMID:8412754 PMID:8413767 PMID:8506949 PMID:9059516 More...
|
|
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
|
|
G |
APOA2 |
apolipoprotein A2 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of APOA2 protein |
CTD |
PMID:7442475 |
|
NCBI chr 1:161,222,292...161,223,628
Ensembl chr 1:161,222,292...161,223,631
|
|
G |
APOA4 |
apolipoprotein A4 |
decreases expression increases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of APOA4 protein Puromycin Aminonucleoside results in increased expression of APOA4 mRNA; Puromycin Aminonucleoside results in increased expression of APOA4 protein |
CTD |
PMID:7442475 PMID:8412754 |
|
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
|
|
G |
APOB |
apolipoprotein B |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of APOB protein |
CTD |
PMID:2725289 PMID:7442475 PMID:8506949 |
|
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
|
|
G |
APOE |
apolipoprotein E |
decreases response to substance increases expression affects expression |
ISO |
APOE protein results in decreased susceptibility to Puromycin Aminonucleoside Puromycin Aminonucleoside results in increased expression of APOE protein Puromycin Aminonucleoside affects the expression of APOE mRNA |
CTD |
PMID:7442475 PMID:8413767 PMID:12472773 |
|
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
|
|
G |
AQP2 |
aquaporin 2 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of AQP2 protein |
CTD |
PMID:9013444 |
|
NCBI chr12:49,950,737...49,958,878
Ensembl chr12:49,950,737...49,958,878
|
|
G |
AQP3 |
aquaporin 3 (Gill blood group) |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of AQP3 protein |
CTD |
PMID:9013444 |
|
NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
|
|
G |
ARC |
activity regulated cytoskeleton associated protein |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ARC mRNA |
CTD |
PMID:19617259 |
|
NCBI chr 8:142,611,049...142,614,479
Ensembl chr 8:142,611,049...142,614,479
|
|
G |
ATP1A1 |
ATPase Na+/K+ transporting subunit alpha 1 |
decreases expression increases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ATP1A1 protein Puromycin Aminonucleoside results in increased expression of ATP1A1 mRNA |
CTD |
PMID:11675400 PMID:15075188 |
|
NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
|
|
G |
ATP1B1 |
ATPase Na+/K+ transporting subunit beta 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ATP1B1 mRNA |
CTD |
PMID:11675400 |
|
NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
|
|
G |
ATP2A2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ATP2A2 mRNA; Puromycin Aminonucleoside results in decreased expression of ATP2A2 protein |
CTD |
PMID:17457379 |
|
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
|
|
G |
AVP |
arginine vasopressin |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of AVP protein |
CTD |
PMID:7810534 |
|
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of BAX protein Dinoprostone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein] Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein] |
CTD |
PMID:15113391 PMID:15987750 PMID:16152783 PMID:16396944 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCAT2 |
branched chain amino acid transaminase 2 |
decreases activity decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased activity of BCAT2 protein Puromycin Aminonucleoside results in decreased expression of BCAT2 mRNA |
CTD |
PMID:9399633 |
|
NCBI chr19:48,795,064...48,811,029
Ensembl chr19:48,795,062...48,811,029
|
|
G |
BCHE |
butyrylcholinesterase |
increases activity |
ISO |
Puromycin Aminonucleoside results in increased activity of BCHE protein |
CTD |
PMID:1462003 |
|
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions increases expression |
ISO |
[Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein Puromycin Aminonucleoside results in increased expression of BCL2 protein |
CTD |
PMID:14993511 PMID:15113391 PMID:16152783 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions decreases expression |
ISO |
[Puromycin Aminonucleoside co-treated with pifithrin] results in increased expression of BCL2L1 protein; Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] Dinoprostone affects the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] |
CTD |
PMID:15987750 PMID:16396944 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of BGLAP protein |
CTD |
PMID:9154658 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of BIRC5 mRNA; Puromycin Aminonucleoside results in increased expression of BIRC5 protein |
CTD |
PMID:19617259 |
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
BMP7 |
bone morphogenetic protein 7 |
multiple interactions decreases expression |
ISO |
1,25-dihydroxyvitamin D inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of BMP7 mRNA]; 1,25-dihydroxyvitamin D inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of BMP7 protein] Puromycin Aminonucleoside results in decreased expression of BMP7 mRNA; Puromycin Aminonucleoside results in decreased expression of BMP7 protein |
CTD |
PMID:19594554 |
|
NCBI chr20:57,168,753...57,266,641
Ensembl chr20:57,168,753...57,266,641
|
|
G |
BMPR2 |
bone morphogenetic protein receptor type 2 |
multiple interactions increases expression |
ISO |
Drugs, Chinese Herbal inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BMPR2 mRNA]; Fosinopril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BMPR2 mRNA] |
CTD |
PMID:17803470 |
|
NCBI chr 2:202,376,327...202,567,749
Ensembl chr 2:202,376,327...202,567,751
|
|
G |
C3 |
complement C3 |
multiple interactions increases expression decreases expression |
ISO |
cobra venom factor inhibits the reaction [Puromycin Aminonucleoside results in increased expression of C3 protein]; mizoribine inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of C3 protein] |
CTD |
PMID:8919236 PMID:9250166 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C5 |
complement C5 |
multiple interactions |
EXP ISO |
CR1 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein]] cobra venom factor inhibits the reaction [Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein]]; Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein] |
CTD |
PMID:9250166 |
|
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
C9 |
complement C9 |
multiple interactions |
EXP ISO |
CR1 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein]] cobra venom factor inhibits the reaction [Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein]]; Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein] |
CTD |
PMID:9250166 |
|
NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,284,140...39,371,324
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
ISO |
Colforsin inhibits the reaction [Puromycin Aminonucleoside results in increased activity of CASP3 protein]; Dinoprostone inhibits the reaction [Puromycin Aminonucleoside results in increased activity of CASP3 protein]; L-161982 promotes the reaction [Puromycin Aminonucleoside results in increased activity of CASP3 protein] |
CTD |
PMID:16396944 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
increases activity decreases activity decreases expression affects activity multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased activity of CAT protein Puromycin Aminonucleoside results in decreased activity of CAT protein Puromycin Aminonucleoside results in decreased expression of CAT mRNA Puromycin Aminonucleoside affects the activity of CAT protein [Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of CAT protein; Cyclosporine inhibits the reaction [Puromycin Aminonucleoside results in decreased activity of CAT protein]; Puromycin Aminonucleoside results in decreased expression of and results in decreased activity of CAT protein; sho-saiko-to-kyo-shokyo-ka-oren-bukuryo inhibits the reaction [Puromycin Aminonucleoside results in decreased activity of CAT protein] |
CTD |
PMID:1744988 PMID:1942778 PMID:6246912 PMID:8289993 PMID:9355075 PMID:10468195 PMID:15113391 PMID:15496159 PMID:20685819 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL1 |
C-C motif chemokine ligand 1 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of CCL1 mRNA |
CTD |
PMID:10867541 |
|
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
affects expression increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside affects the expression of CCL2 mRNA Puromycin Aminonucleoside results in increased expression of CCL2 mRNA; Puromycin Aminonucleoside results in increased expression of CCL2 protein fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 mRNA]; Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 protein] |
CTD |
PMID:10867541 PMID:12813006 PMID:16452496 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of CCL3 mRNA |
CTD |
PMID:10867541 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of CCL7 mRNA |
CTD |
PMID:10867541 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CD2AP |
CD2 associated protein |
multiple interactions decreases expression |
ISO |
celecoxib inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CD2AP mRNA] |
CTD |
PMID:19194550 |
|
NCBI chr 6:47,477,789...47,627,263
Ensembl chr 6:47,477,789...47,627,263
|
|
G |
CD36 |
CD36 molecule (CD36 blood group) |
multiple interactions increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of and results in increased glycosylation of CD36 protein Puromycin Aminonucleoside results in increased expression of CD36 mRNA |
CTD |
PMID:19264907 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CD44 |
CD44 molecule (IN blood group) |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of CD44 protein |
CTD |
PMID:8635280 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CDKN1A protein] |
CTD |
PMID:17035936 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CHST11 |
carbohydrate sulfotransferase 11 |
decreases expression |
EXP |
Puromycin Aminonucleoside results in decreased expression of CHST11 mRNA |
CTD |
PMID:15585670 |
|
NCBI chr12:104,456,948...104,762,014
Ensembl chr12:104,455,295...104,762,014
|
|
G |
CHSY1 |
chondroitin sulfate synthase 1 |
decreases expression |
EXP |
Puromycin Aminonucleoside results in decreased expression of CHSY1 mRNA |
CTD |
PMID:15585670 |
|
NCBI chr15:101,175,727...101,252,048
Ensembl chr15:101,175,727...101,252,048
|
|
G |
CLDN6 |
claudin 6 |
affects localization |
ISO |
Puromycin Aminonucleoside affects the localization of CLDN6 protein |
CTD |
PMID:18367650 |
|
NCBI chr16:3,014,712...3,018,183
Ensembl chr16:3,014,712...3,020,071
|
|
G |
CLIC5 |
chloride intracellular channel 5 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of CLIC5 protein |
CTD |
PMID:19264907 |
|
NCBI chr 6:45,880,827...46,129,819
Ensembl chr 6:45,880,827...46,080,348
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
ISO |
4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL1A1 mRNA] |
CTD |
PMID:9527400 PMID:16570917 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of COL3A1 mRNA |
CTD |
PMID:9527400 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COL4A1 |
collagen type IV alpha 1 chain |
multiple interactions increases expression |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL4A1 mRNA]; FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL4A1 mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL4A1 mRNA] |
CTD |
PMID:1762292 PMID:9175058 |
|
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,157
|
|
G |
CORIN |
corin, serine peptidase |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of CORIN mRNA; Puromycin Aminonucleoside results in decreased expression of CORIN protein |
CTD |
PMID:20613715 |
|
NCBI chr 4:47,594,001...47,838,067
Ensembl chr 4:47,593,999...47,838,106
|
|
G |
CR1 |
complement C3b/C4b receptor 1 (Knops blood group) |
multiple interactions |
EXP |
CR1 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of [C5 protein alternative form binds to C9 protein]] |
CTD |
PMID:9250166 |
|
NCBI chr 1:207,496,157...207,641,765
Ensembl chr 1:207,496,147...207,641,765
|
|
G |
CTNNB1 |
catenin beta 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of CTNNB1 protein |
CTD |
PMID:12065681 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CTSB |
cathepsin B |
decreases activity |
ISO |
Puromycin Aminonucleoside results in decreased activity of CTSB protein |
CTD |
PMID:10394110 |
|
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
|
|
G |
CTSD |
cathepsin D |
increases activity |
ISO |
Puromycin Aminonucleoside results in increased activity of CTSD protein |
CTD |
PMID:6497855 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CTSH |
cathepsin H |
decreases activity |
ISO |
Puromycin Aminonucleoside results in decreased activity of CTSH protein |
CTD |
PMID:10394110 |
|
NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574
|
|
G |
CTSL |
cathepsin L |
decreases response to substance multiple interactions decreases activity affects expression |
ISO |
CTSL gene mutant form results in decreased susceptibility to Puromycin Aminonucleoside Puromycin Aminonucleoside results in increased activity of and results in increased expression of CTSL protein Puromycin Aminonucleoside results in decreased activity of CTSL protein Puromycin Aminonucleoside affects the expression of CTSL mRNA; Puromycin Aminonucleoside affects the expression of CTSL protein |
CTD |
PMID:10394110 PMID:15197181 |
|
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
|
|
G |
CYP11A1 |
cytochrome P450 family 11 subfamily A member 1 |
multiple interactions decreases expression |
ISO |
[FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA]; CGB3 protein inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA]; FSHB protein inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:16574160 |
|
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
|
|
G |
CYP24A1 |
cytochrome P450 family 24 subfamily A member 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of CYP24A1 mRNA |
CTD |
PMID:19297354 |
|
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
|
|
G |
CYP27B1 |
cytochrome P450 family 27 subfamily B member 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of CYP27B1 mRNA |
CTD |
PMID:19297354 |
|
NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
|
|
G |
DDC |
dopa decarboxylase |
decreases activity |
ISO |
Puromycin Aminonucleoside results in decreased activity of DDC protein |
CTD |
PMID:16204272 |
|
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
|
|
G |
DDN |
dendrin |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of DDN protein |
CTD |
PMID:20588063 |
|
NCBI chr12:48,995,149...48,999,375
Ensembl chr12:48,995,149...48,999,375
|
|
G |
DES |
desmin |
increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of DES protein triptolide inhibits the reaction [Puromycin Aminonucleoside results in increased expression of DES protein] |
CTD |
PMID:2183627 PMID:18509322 |
|
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
|
|
G |
DNM3 |
dynamin 3 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of DNM3 mRNA |
CTD |
PMID:19617259 |
|
NCBI chr 1:171,841,498...172,418,466
Ensembl chr 1:171,817,887...172,418,466
|
|
G |
ECE1 |
endothelin converting enzyme 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ECE1 mRNA; Puromycin Aminonucleoside results in increased expression of ECE1 protein |
CTD |
PMID:12972712 |
|
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
|
|
G |
ECHS1 |
enoyl-CoA hydratase, short chain 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ECHS1 protein |
CTD |
PMID:19264907 |
|
NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions increases expression |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDN1 mRNA]; FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDN1 mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDN1 mRNA]; Puromycin Aminonucleoside inhibits the reaction [EDN1 protein results in increased abundance of Cyclic GMP] |
CTD |
PMID:7756592 PMID:9175058 PMID:12972712 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDN3 |
endothelin 3 |
multiple interactions |
ISO |
Puromycin Aminonucleoside promotes the reaction [EDN3 protein results in increased abundance of Cyclic GMP] |
CTD |
PMID:12972712 |
|
NCBI chr20:59,300,611...59,325,992
Ensembl chr20:59,300,443...59,325,992
|
|
G |
EDNRA |
endothelin receptor type A |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of EDNRA mRNA |
CTD |
PMID:12972712 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
multiple interactions increases expression |
ISO |
Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDNRB mRNA] |
CTD |
PMID:7756592 |
|
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
ETFA |
electron transfer flavoprotein subunit alpha |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ETFA protein |
CTD |
PMID:19264907 |
|
NCBI chr15:76,215,353...76,311,469
Ensembl chr15:76,188,555...76,311,730
|
|
G |
ETFB |
electron transfer flavoprotein subunit beta |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of ETFB protein |
CTD |
PMID:19264907 |
|
NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388
|
|
G |
EZR |
ezrin |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of EZR protein |
CTD |
PMID:19264907 |
|
NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FAS protein] |
CTD |
PMID:14993511 PMID:16152783 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of FASL protein Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FASLG protein] |
CTD |
PMID:14993511 PMID:16152783 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FAT1 |
FAT atypical cadherin 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of FAT1 mRNA; Puromycin Aminonucleoside results in increased expression of FAT1 protein |
CTD |
PMID:16014031 |
|
NCBI chr 4:186,587,794...186,726,696
Ensembl chr 4:186,587,794...186,726,722
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
increases expression affects expression |
ISO |
Puromycin Aminonucleoside results in increased expression of FLT1 protein Puromycin Aminonucleoside affects the expression of FLT1 mRNA |
CTD |
PMID:11744811 PMID:14752241 |
|
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
|
|
G |
FN1 |
fibronectin 1 |
increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of FN1 mRNA; Puromycin Aminonucleoside results in increased expression of FN1 protein Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FN1 protein] |
CTD |
PMID:9527400 PMID:12813006 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions decreases expression |
ISO |
[FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Estradiol]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Progesterone]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Testosterone]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of STAR mRNA]; FSHB protein inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA]; Puromycin Aminonucleoside inhibits the reaction [GNRH1 protein results in increased secretion of FSHB protein] Puromycin Aminonucleoside results in decreased expression of FSHB protein |
CTD |
PMID:12269381 PMID:16574160 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
GNAQ |
G protein subunit alpha q |
increases response to substance |
ISO |
GNAQ protein results in increased susceptibility to Puromycin Aminonucleoside |
CTD |
PMID:16267159 |
|
NCBI chr 9:77,716,097...78,031,811
Ensembl chr 9:77,716,097...78,031,811
|
|
G |
GNRH1 |
gonadotropin releasing hormone 1 |
multiple interactions |
ISO |
Puromycin Aminonucleoside inhibits the reaction [GNRH1 protein results in increased secretion of FSHB protein]; Puromycin Aminonucleoside inhibits the reaction [GNRH1 protein results in increased secretion of LHB protein] |
CTD |
PMID:12269381 |
|
NCBI chr 8:25,419,258...25,425,040
Ensembl chr 8:25,419,258...25,424,654
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of GPX1 protein Puromycin Aminonucleoside results in increased expression of GPX1 mRNA |
CTD |
PMID:1942778 PMID:20685819 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX3 |
glutathione peroxidase 3 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of GPX3 mRNA |
CTD |
PMID:20685819 |
|
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions increases phosphorylation |
ISO |
mizoribine inhibits the reaction [Puromycin Aminonucleoside results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:20502051 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of GSTP1 protein |
CTD |
PMID:19264907 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GUCA2B |
guanylate cyclase activator 2B |
increases expression affects expression |
ISO |
Puromycin Aminonucleoside results in increased expression of GUCA2B protein Puromycin Aminonucleoside affects the expression of GUCA2B mRNA |
CTD |
PMID:15590761 |
|
NCBI chr 1:42,153,410...42,155,820
Ensembl chr 1:42,153,410...42,155,820
|
|
G |
HADH |
hydroxyacyl-CoA dehydrogenase |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of HADH protein |
CTD |
PMID:19264907 |
|
NCBI chr 4:107,989,889...108,035,171
Ensembl chr 4:107,989,714...108,035,241
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases activity |
ISO |
Puromycin Aminonucleoside results in increased activity of HMGCR protein |
CTD |
PMID:3794548 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
[piperine co-treated with Cimetidine co-treated with Pyruvates] inhibits the reaction [Puromycin Aminonucleoside results in increased expression of HMOX1 protein] Puromycin Aminonucleoside results in increased expression of HMOX1 mRNA; Puromycin Aminonucleoside results in increased expression of HMOX1 protein |
CTD |
PMID:12806184 PMID:20685819 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HPSE |
heparanase |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of HPSE mRNA; Puromycin Aminonucleoside results in increased expression of HPSE protein |
CTD |
PMID:11576343 |
|
NCBI chr 4:83,292,461...83,335,153
Ensembl chr 4:83,292,461...83,335,153
|
|
G |
HS3ST1 |
heparan sulfate-glucosamine 3-sulfotransferase 1 |
decreases expression |
EXP |
Puromycin Aminonucleoside results in decreased expression of HS3ST1 mRNA |
CTD |
PMID:15585670 |
|
NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564
|
|
G |
HS6ST1 |
heparan sulfate 6-O-sulfotransferase 1 |
decreases expression |
EXP |
Puromycin Aminonucleoside results in decreased expression of HS6ST1 mRNA |
CTD |
PMID:15585670 |
|
NCBI chr 2:128,265,480...128,318,868
Ensembl chr 2:128,236,716...128,318,868
|
|
G |
HSD11B2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases activity |
ISO |
Puromycin Aminonucleoside results in decreased activity of HSD11B2 protein |
CTD |
PMID:11981059 |
|
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of HSPA5 protein |
CTD |
PMID:19264907 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
affects localization |
ISO |
Puromycin Aminonucleoside affects the localization of HSPA8 protein |
CTD |
PMID:1614035 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of HSPD1 protein |
CTD |
PMID:19264907 |
|
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of ICAM1 protein |
CTD |
PMID:8635280 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL1B |
interleukin 1 beta |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of IL1B mRNA |
CTD |
PMID:17457379 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
ILK |
integrin linked kinase |
multiple interactions increases activity |
ISO |
mizoribine inhibits the reaction [Puromycin Aminonucleoside results in increased activity of ILK protein] |
CTD |
PMID:20502051 |
|
NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
|
|
G |
ITGA3 |
integrin subunit alpha 3 |
decreases expression affects expression |
EXP ISO |
Puromycin Aminonucleoside results in decreased expression of ITGA3 mRNA; Puromycin Aminonucleoside results in decreased expression of ITGA3 protein Puromycin Aminonucleoside affects the expression of ITGA3 protein |
CTD |
PMID:9249603 PMID:10845833 PMID:11274237 PMID:15197181 |
|
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
|
|
G |
ITGB1 |
integrin subunit beta 1 |
decreases expression increases expression |
EXP ISO |
Puromycin Aminonucleoside results in decreased expression of ITGB1 mRNA; Puromycin Aminonucleoside results in decreased expression of ITGB1 protein Puromycin Aminonucleoside results in increased expression of ITGB1 protein |
CTD |
PMID:11274237 PMID:12065681 PMID:14559718 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
G |
KDR |
kinase insert domain receptor |
affects expression increases expression decreases expression |
ISO |
Puromycin Aminonucleoside affects the expression of KDR mRNA Puromycin Aminonucleoside results in increased expression of KDR mRNA; Puromycin Aminonucleoside results in increased expression of KDR protein Puromycin Aminonucleoside results in decreased expression of KDR mRNA |
CTD |
PMID:11744811 PMID:14752241 PMID:17667850 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KIRREL1 |
kirre like nephrin family adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
Y 27632 inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of KIRREL1 mRNA] |
CTD |
PMID:18367845 |
|
NCBI chr 1:157,993,645...158,100,262
Ensembl chr 1:157,993,273...158,100,262
|
|
G |
KRT7 |
keratin 7 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of KRT7 mRNA; Puromycin Aminonucleoside results in decreased expression of KRT7 protein |
CTD |
PMID:19617259 |
|
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
|
|
G |
LAMB1 |
laminin subunit beta 1 |
multiple interactions increases expression |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]; FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA] |
CTD |
PMID:1762292 PMID:9175058 |
|
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
|
|
G |
LAMB2 |
laminin subunit beta 2 |
multiple interactions increases expression |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB2 mRNA]; FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB2 mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB2 mRNA] |
CTD |
PMID:1762292 PMID:9175058 |
|
NCBI chr 3:49,121,114...49,133,050
Ensembl chr 3:49,121,114...49,133,118
|
|
G |
LCN2 |
lipocalin 2 |
increases secretion |
ISO |
Puromycin Aminonucleoside results in increased secretion of LCN2 protein |
CTD |
PMID:20438795 |
|
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
LGALS1 |
galectin 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of LGALS1 protein |
CTD |
PMID:19079321 |
|
NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
|
|
G |
LHB |
luteinizing hormone subunit beta |
multiple interactions decreases expression |
ISO |
[FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Estradiol]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Progesterone]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased abundance of Testosterone]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA]; [FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of STAR mRNA]; CGB3 protein inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of CYP11A1 mRNA]; Puromycin Aminonucleoside inhibits the reaction [GNRH1 protein results in increased secretion of LHB protein] Puromycin Aminonucleoside results in decreased expression of LHB protein |
CTD |
PMID:12269381 PMID:16574160 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of and results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:14559718 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of and results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:14559718 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Puromycin Aminonucleoside binds to and results in increased activity of MAPK8 protein |
CTD |
PMID:15351692 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MDK |
midkine |
multiple interactions decreases expression |
ISO |
Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of MDK mRNA] |
CTD |
PMID:12660332 |
|
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
|
|
G |
MME |
membrane metalloendopeptidase |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of MME protein |
CTD |
PMID:19885019 |
|
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions increases expression |
ISO |
FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of MMP2 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MSN |
moesin |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of MSN protein |
CTD |
PMID:19264907 |
|
NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931
|
|
G |
MT-CO1 |
mitochondrially encoded cytochrome c oxidase I |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of COX1 protein |
CTD |
PMID:16609681 |
|
NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
|
|
G |
MYH10 |
myosin heavy chain 10 |
increases expression affects expression |
ISO |
Puromycin Aminonucleoside results in increased expression of MYH10 protein Puromycin Aminonucleoside affects the expression of MYH10 mRNA; Puromycin Aminonucleoside affects the expression of MYH10 protein |
CTD |
PMID:7671567 PMID:8918620 |
|
NCBI chr17:8,474,212...8,630,725
Ensembl chr17:8,474,207...8,631,376
|
|
G |
MYH6 |
myosin heavy chain 6 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of MYH6 mRNA |
CTD |
PMID:17457379 |
|
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
|
|
G |
NAPSA |
napsin A aspartic peptidase |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of NAPSA mRNA; Puromycin Aminonucleoside results in increased expression of NAPSA protein |
CTD |
PMID:12501893 |
|
NCBI chr19:50,358,477...50,365,639
Ensembl chr19:50,358,472...50,365,830
|
|
G |
NDST1 |
N-deacetylase and N-sulfotransferase 1 |
decreases expression affects expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of NDST1 mRNA Puromycin Aminonucleoside affects the expression of NDST1 mRNA |
CTD |
PMID:14966466 |
|
NCBI chr 5:150,497,779...150,558,211
Ensembl chr 5:150,485,818...150,558,211
|
|
G |
NEBL |
nebulette |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of NEBL mRNA |
CTD |
PMID:19617259 |
|
NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011
|
|
G |
NEDD4L |
NEDD4 like E3 ubiquitin protein ligase |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of NEDD4L protein |
CTD |
PMID:16020936 |
|
NCBI chr18:58,044,226...58,401,540
Ensembl chr18:58,044,226...58,401,540
|
|
G |
NOS1 |
nitric oxide synthase 1 |
multiple interactions increases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of and results in decreased activity of NOS1 protein Puromycin Aminonucleoside results in increased expression of NOS1 mRNA |
CTD |
PMID:15039144 |
|
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
|
|
G |
NOS2 |
nitric oxide synthase 2 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of NOS2 mRNA |
CTD |
PMID:15039144 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of NOS3 mRNA Puromycin Aminonucleoside results in decreased expression of and results in decreased activity of NOS3 protein |
CTD |
PMID:15039144 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NPHS2 |
NPHS2 stomatin family member, podocin |
decreases expression multiple interactions affects expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of NPHS2 protein triptolide inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS2 protein] Puromycin Aminonucleoside affects the expression of NPHS2 mRNA; Puromycin Aminonucleoside affects the expression of NPHS2 protein |
CTD |
PMID:12065681 PMID:15363039 PMID:18509322 |
|
NCBI chr 1:179,550,539...179,575,948
Ensembl chr 1:179,550,539...179,575,952
|
|
G |
NPPA |
natriuretic peptide A |
affects metabolic processing increases response to substance increases expression multiple interactions affects expression |
ISO |
Puromycin Aminonucleoside affects the metabolism of NPPA protein Puromycin Aminonucleoside results in increased susceptibility to NPPA protein Puromycin Aminonucleoside results in increased expression of NPPA mRNA; Puromycin Aminonucleoside results in increased expression of NPPA protein Puromycin Aminonucleoside inhibits the reaction [NPPA protein results in increased abundance of Cyclic GMP] Puromycin Aminonucleoside affects the expression of NPPA protein |
CTD |
PMID:2526952 PMID:12972712 PMID:15590761 PMID:19885019 PMID:20613715 |
|
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G |
NPPB |
natriuretic peptide B |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of NPPB mRNA |
CTD |
PMID:17457379 |
|
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
|
|
G |
NPR1 |
natriuretic peptide receptor 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of NPR1 mRNA |
CTD |
PMID:19885019 |
|
NCBI chr 1:153,678,688...153,693,992
Ensembl chr 1:153,678,688...153,693,992
|
|
G |
NPR3 |
natriuretic peptide receptor 3 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of NPR3 mRNA |
CTD |
PMID:19885019 |
|
NCBI chr 5:32,690,872...32,791,720
Ensembl chr 5:32,689,070...32,791,724
|
|
G |
NRF1 |
nuclear respiratory factor 1 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of NRF1 mRNA |
CTD |
PMID:16609681 |
|
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
|
|
G |
OPTN |
optineurin |
increases expression |
ISO EXP |
Puromycin Aminonucleoside results in increased expression of OPTN protein |
CTD |
PMID:25096716 |
|
NCBI chr10:13,100,082...13,138,308
Ensembl chr10:13,099,449...13,138,308
|
|
G |
PDPN |
podoplanin |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of PDPN mRNA; Puromycin Aminonucleoside results in decreased expression of PDPN protein |
CTD |
PMID:9327748 PMID:12032185 |
|
NCBI chr 1:13,583,757...13,617,957
Ensembl chr 1:13,583,465...13,617,957
|
|
G |
PLEKHH2 |
pleckstrin homology, MyTH4 and FERM domain containing H2 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of PLEKHH2 protein |
CTD |
PMID:20588063 |
|
NCBI chr 2:43,637,260...43,767,987
Ensembl chr 2:43,637,260...43,767,987
|
|
G |
PLN |
phospholamban |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of PLN mRNA |
CTD |
PMID:17457379 |
|
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
|
|
G |
PODXL |
podocalyxin like |
increases expression affects metabolic processing |
EXP ISO |
Puromycin Aminonucleoside results in increased expression of PODXL mRNA; Puromycin Aminonucleoside results in increased expression of PODXL protein Puromycin Aminonucleoside affects the metabolism of PODXL protein |
CTD |
PMID:8780404 PMID:11274237 |
|
NCBI chr 7:131,500,271...131,556,628
Ensembl chr 7:131,500,262...131,558,217
|
|
G |
POLB |
DNA polymerase beta |
increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of POLB protein 1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of POLB protein] |
CTD |
PMID:17035936 |
|
NCBI chr 8:42,338,494...42,371,808
Ensembl chr 8:42,338,454...42,371,808
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions increases expression |
ISO |
pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] |
CTD |
PMID:16598202 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPP1R12A |
protein phosphatase 1 regulatory subunit 12A |
increases phosphorylation increases expression multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased phosphorylation of PPP1R12A protein Puromycin Aminonucleoside results in increased expression of PPP1R12A protein modified form Y 27632 inhibits the reaction [Puromycin Aminonucleoside results in increased phosphorylation of PPP1R12A protein] fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of PPP1R12A protein modified form] |
CTD |
PMID:16452496 PMID:18367845 |
|
NCBI chr12:79,773,563...79,935,460
Ensembl chr12:79,773,563...79,935,460
|
|
G |
PRDX3 |
peroxiredoxin 3 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of PRDX3 protein |
CTD |
PMID:19264907 |
|
NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression affects response to substance multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of PTGS2 mRNA; Puromycin Aminonucleoside results in increased expression of PTGS2 protein PTGS2 protein affects the susceptibility to Puromycin Aminonucleoside celecoxib inhibits the reaction [Puromycin Aminonucleoside results in increased expression of PTGS2 mRNA] |
CTD |
PMID:16396944 PMID:17890881 PMID:19194550 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTH |
parathyroid hormone |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of PTH protein |
CTD |
PMID:1328752 |
|
NCBI chr11:13,492,054...13,496,181
Ensembl chr11:13,492,054...13,496,181
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of and results in increased phosphorylation of PTK2 protein |
CTD |
PMID:14559718 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
PTPRO |
protein tyrosine phosphatase receptor type O |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of PTPRO mRNA; Puromycin Aminonucleoside affects the expression of PTPRO protein |
CTD |
PMID:11961407 |
|
NCBI chr12:15,322,508...15,598,331
Ensembl chr12:15,322,257...15,602,175
|
|
G |
RARA |
retinoic acid receptor alpha |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of RARA mRNA; Puromycin Aminonucleoside results in increased expression of RARA protein |
CTD |
PMID:12660332 |
|
NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
|
|
G |
RBBP7 |
RB binding protein 7, chromatin remodeling factor |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of RBBP7 protein |
CTD |
PMID:15798086 |
|
NCBI chr X:16,844,341...16,870,362
Ensembl chr X:16,839,283...16,870,362
|
|
G |
REN |
renin |
multiple interactions increases expression affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of and affects the activity of REN protein; Puromycin Aminonucleoside results in increased expression of and results in increased activity of REN protein Puromycin Aminonucleoside results in increased expression of REN protein Puromycin Aminonucleoside affects the expression of REN protein |
CTD |
PMID:2236972 PMID:2267444 PMID:8446257 PMID:9171944 |
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RHOA |
ras homolog family member A |
multiple interactions increases expression |
ISO |
fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of RHOA protein] |
CTD |
PMID:16452496 |
|
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
|
|
G |
SCNN1A |
sodium channel epithelial 1 subunit alpha |
affects expression multiple interactions decreases expression affects localization |
ISO |
Puromycin Aminonucleoside affects the expression of SCNN1A mRNA Puromycin Aminonucleoside results in increased expression of and results in increased localization of SCNN1A protein Puromycin Aminonucleoside results in decreased expression of SCNN1A mRNA Puromycin Aminonucleoside affects the localization of SCNN1A protein |
CTD |
PMID:12653683 PMID:15075188 PMID:16020936 PMID:16267158 |
|
NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
|
|
G |
SCNN1B |
sodium channel epithelial 1 subunit beta |
affects expression increases expression decreases expression multiple interactions affects localization |
ISO |
Puromycin Aminonucleoside affects the expression of SCNN1B mRNA Puromycin Aminonucleoside results in increased expression of SCNN1B mRNA Puromycin Aminonucleoside results in decreased expression of SCNN1B mRNA Puromycin Aminonucleoside results in increased expression of and results in increased localization of SCNN1B protein Puromycin Aminonucleoside affects the localization of SCNN1B protein |
CTD |
PMID:12653683 PMID:15075188 PMID:16020936 PMID:16267158 |
|
NCBI chr16:23,278,231...23,381,294
Ensembl chr16:23,278,231...23,381,294
|
|
G |
SCNN1G |
sodium channel epithelial 1 subunit gamma |
multiple interactions increases expression decreases expression |
ISO |
Puromycin Aminonucleoside affects the localization of and affects the expression of SCNN1G protein; Puromycin Aminonucleoside results in increased expression of and results in increased localization of SCNN1G protein Puromycin Aminonucleoside results in increased expression of SCNN1G mRNA Puromycin Aminonucleoside results in decreased expression of SCNN1G mRNA |
CTD |
PMID:12653683 PMID:15075188 PMID:16020936 PMID:16267158 |
|
NCBI chr16:23,182,745...23,216,883
Ensembl chr16:23,182,745...23,216,883
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions increases expression |
ISO |
pioglitazone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:16598202 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC12A1 |
solute carrier family 12 member 1 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of SLC12A1 protein |
CTD |
PMID:15075188 |
|
NCBI chr15:48,206,302...48,304,078
Ensembl chr15:48,178,438...48,304,078
|
|
G |
SLC12A3 |
solute carrier family 12 member 3 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of SLC12A3 protein |
CTD |
PMID:15075188 |
|
NCBI chr16:56,865,207...56,915,850
Ensembl chr16:56,865,207...56,915,850
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of SLC22A2 mRNA |
CTD |
PMID:22005293 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SLC29A4 |
solute carrier family 29 member 4 |
increases response to substance |
EXP |
SLC29A4 results in increased susceptibility to Puromycin Aminonucleoside |
CTD |
PMID:19357181 |
|
NCBI chr 7:5,282,943...5,306,912
Ensembl chr 7:5,274,369...5,306,912
|
|
G |
SLC5A3 |
solute carrier family 5 member 3 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of SLC5A3 mRNA |
CTD |
PMID:15031335 |
|
NCBI chr21:34,073,578...34,106,260
Ensembl chr21:34,073,578...34,106,260
|
|
G |
SLC9A3 |
solute carrier family 9 member A3 |
multiple interactions decreases expression affects expression |
ISO |
[piperine co-treated with Cimetidine co-treated with Pyruvates] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of SLC9A3 protein] Puromycin Aminonucleoside affects the expression of SLC9A3 protein |
CTD |
PMID:12191963 PMID:12806184 PMID:15075188 |
|
NCBI chr 5:470,456...524,449
Ensembl chr 5:470,456...524,449
|
|
G |
SMAD1 |
SMAD family member 1 |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of SMAD1 mRNA |
CTD |
PMID:17803470 |
|
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
|
|
G |
SOD2 |
superoxide dismutase 2 |
affects expression decreases expression multiple interactions |
ISO |
Puromycin Aminonucleoside affects the expression of SOD2 protein Puromycin Aminonucleoside results in decreased expression of SOD2 protein [Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of SOD2 protein |
CTD |
PMID:1942778 PMID:19264907 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SOD3 |
superoxide dismutase 3 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of SOD3 mRNA |
CTD |
PMID:20685819 |
|
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
|
|
G |
SPMIP11 |
sperm microtubule inner protein 11 |
multiple interactions decreases expression affects expression decreases phosphorylation |
ISO |
1,25-dihydroxyvitamin D inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 mRNA]; 1,25-dihydroxyvitamin D inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein]; Celecoxib inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 mRNA]; fasudil inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein]; Fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 mRNA]; Mercuric Chloride promotes the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein]; Puromycin Aminonucleoside affects the expression of and affects the localization of NPHS1 protein; Puromycin Aminonucleoside promotes the reaction [Mercuric Chloride results in decreased expression of NPHS1 mRNA]; Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 mRNA]; Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein]; triptolide inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein] Puromycin Aminonucleoside results in decreased expression of NPHS1; Puromycin Aminonucleoside results in decreased expression of NPHS1 mRNA; Puromycin Aminonucleoside results in decreased expression of NPHS1 protein Puromycin Aminonucleoside affects the expression of NPHS1 mRNA; Puromycin Aminonucleoside affects the expression of NPHS1 protein Puromycin Aminonucleoside results in decreased phosphorylation of NPHS1 protein |
CTD |
PMID:10792613 PMID:11012881 PMID:12012391 PMID:12065681 PMID:12386277 PMID:12660332 PMID:15363039 PMID:15385636 PMID:16452496 PMID:18256598 PMID:18509322 PMID:19079321 PMID:19194550 PMID:19443634 PMID:19594554 PMID:20071462 PMID:20540862 PMID:20588063 More...
|
|
NCBI chr12:48,727,435...48,771,459
Ensembl chr12:48,727,435...48,765,790
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
multiple interactions increases expression |
ISO |
Drugs, Chinese Herbal inhibits the reaction [Puromycin Aminonucleoside results in increased expression of SPP1 protein]; fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of SPP1 mRNA] Puromycin Aminonucleoside results in increased expression of SPP1 mRNA; Puromycin Aminonucleoside results in increased expression of SPP1 protein |
CTD |
PMID:14738908 PMID:16452496 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased expression of and results in increased phosphorylation of SRC protein |
CTD |
PMID:14559718 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions decreases expression |
ISO |
[FSHB protein co-treated with CGB3 protein] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of STAR mRNA] |
CTD |
PMID:16574160 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
SYNPO |
synaptopodin |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of SYNPO protein |
CTD |
PMID:15798086 |
|
NCBI chr 5:150,586,010...150,659,207
Ensembl chr 5:150,601,080...150,659,207
|
|
G |
TAGLN |
transgelin |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of TAGLN mRNA; Puromycin Aminonucleoside results in increased expression of TAGLN protein |
CTD |
PMID:19617259 |
|
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
|
|
G |
TEK |
TEK receptor tyrosine kinase |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of TEK mRNA |
CTD |
PMID:17667850 |
|
NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
|
|
G |
TF |
transferrin |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of TF mRNA |
CTD |
PMID:8413769 |
|
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
|
|
G |
TFAM |
transcription factor A, mitochondrial |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of TFAM mRNA |
CTD |
PMID:16609681 |
|
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions increases expression affects expression |
ISO |
Celecoxib inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TGFB1 mRNA]; Drugs, Chinese Herbal inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TGFB1 protein]; Masoprocol inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TGFB1 mRNA] Puromycin Aminonucleoside results in increased expression of TGFB1 mRNA; Puromycin Aminonucleoside results in increased expression of TGFB1 protein Puromycin Aminonucleoside affects the expression of TGFB1 mRNA |
CTD |
PMID:9527400 PMID:12397044 PMID:14738908 PMID:19194550 PMID:19594554 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions increases expression |
ISO |
FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TIMP1 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TJP1 |
tight junction protein 1 |
multiple interactions increases expression affects localization |
ISO |
Cyclosporine inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TJP1 protein] Puromycin Aminonucleoside affects the localization of TJP1 protein |
CTD |
PMID:15744817 PMID:15798086 |
|
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TNF mRNA] |
CTD |
PMID:8384958 PMID:17457379 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNNC1 |
troponin C1, slow skeletal and cardiac type |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of TNNC1 mRNA |
CTD |
PMID:19617259 |
|
NCBI chr 3:52,451,100...52,454,041
Ensembl chr 3:52,451,100...52,454,041
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TP53 protein]; Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TP53 protein] Puromycin Aminonucleoside results in increased expression of TRP53 protein 1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TRP53 protein]; Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TRP53 protein] |
CTD |
PMID:14993511 PMID:15113391 PMID:15987750 PMID:16152783 PMID:17035936 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TTR |
transthyretin |
increases expression |
ISO |
Puromycin Aminonucleoside results in increased expression of TTR protein |
CTD |
PMID:19264907 |
|
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
|
|
G |
UCP3 |
uncoupling protein 3 |
decreases expression |
ISO |
Puromycin Aminonucleoside results in decreased expression of UCP3 protein |
CTD |
PMID:19264907 |
|
NCBI chr11:74,000,277...74,009,085
Ensembl chr11:74,000,277...74,009,085
|
|
G |
VCAN |
versican |
decreases expression |
EXP |
Puromycin Aminonucleoside results in decreased expression of VCAN mRNA; Puromycin Aminonucleoside results in decreased expression of VCAN protein |
CTD |
PMID:15585670 |
|
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
|
|
G |
VCL |
vinculin |
affects localization increases expression |
ISO |
Puromycin Aminonucleoside affects the localization of VCL protein Puromycin Aminonucleoside results in increased expression of VCL mRNA; Puromycin Aminonucleoside results in increased expression of VCL protein |
CTD |
PMID:19617259 |
|
NCBI chr10:73,998,116...74,121,363
Ensembl chr10:73,995,193...74,121,363
|
|
G |
VEGFA |
vascular endothelial growth factor A |
affects expression increases expression |
ISO |
Puromycin Aminonucleoside affects the expression of VEGFA mRNA Puromycin Aminonucleoside results in increased expression of VEGFA protein |
CTD |
PMID:11744811 PMID:14752241 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VIM |
vimentin |
multiple interactions increases expression |
ISO |
fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of VIM mRNA] |
CTD |
PMID:16452496 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
WTIP |
WT1 interacting protein |
affects localization |
ISO |
Puromycin Aminonucleoside affects the localization of WTIP protein |
CTD |
PMID:15798086 |
|
NCBI chr19:34,481,758...34,512,304
Ensembl chr19:34,481,758...34,512,304
|
|
G |
XCL1 |
X-C motif chemokine ligand 1 |
affects expression |
ISO |
Puromycin Aminonucleoside affects the expression of XCL1 mRNA |
CTD |
PMID:10867541 |
|
NCBI chr 1:168,576,605...168,582,069
Ensembl chr 1:168,576,605...168,582,069
|
|
G |
XDH |
xanthine dehydrogenase |
increases activity multiple interactions |
ISO |
Puromycin Aminonucleoside results in increased activity of XDH [Tungsten co-treated with Puromycin Aminonucleoside] results in decreased activity of XDH protein |
CTD |
PMID:7583048 PMID:11041286 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|